C12N 2810/10
Vectors comprising a non-peptidic targeting moiety
C12N2810/10 (Vectors comprising a non-peptidic targeting moiety) appears on 83 US grants and 137 published applications in this corpus.
Search patents in C12N- Granted patents
- 83
- Published applications
- 137
- Assignees
- 87
- Inventors
- 298
- Latest grant
- 4 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1996 | 1 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 3 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 1 |
| 2002 | 0 | 3 |
| 2003 | 2 | 3 |
| 2004 | 4 | 2 |
| 2005 | 0 | 1 |
| 2006 | 0 | 2 |
| 2007 | 0 | 0 |
| 2008 | 0 | 2 |
| 2009 | 2 | 4 |
| 2010 | 1 | 7 |
| 2011 | 0 | 5 |
| 2012 | 1 | 4 |
| 2013 | 2 | 3 |
| 2014 | 9 | 11 |
| 2015 | 3 | 8 |
| 2016 | 4 | 5 |
| 2017 | 8 | 8 |
| 2018 | 7 | 8 |
| 2019 | 4 | 10 |
| 2020 | 6 | 14 |
| 2021 | 2 | 11 |
| 2022 | 2 | 5 |
| 2023 | 9 | 4 |
| 2024 | 7 | 6 |
| 2025 | 2 | 7 |
| 2026 | 3 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Modified adeno-associated virus vectors and delivery thereof into the central nervous system4 Aug 2026US 12,697,397 B2Coave Therapeutics
- DNA sequence modification-based gene drive17 Mar 2026US 12,577,583 B2California Institute of Technology
- Orthogonal Cas9 proteins for RNA-guided gene regulation and editing17 Mar 2026US 12,577,590 B2President and Fellows of Harvard College
- Engineered multi-component system for identification and characterisation of T-cell receptors and T-cell antigens8 Apr 2025US 12,270,047 B2Genovie AB
- Systems and methods for one-shot guide RNA (ogRNA) targeting of endogenous and source DNA1 Apr 2025US 12,264,331 B2Editas Medicine, Inc.
- Nuclear Targeted DNA Delivery and Compositions for Use in Practicing the Same13 Aug 2026US 2026/0234655 A1Seawolf Therapeutics, Inc.
- Genome editing using cas9 nickases30 Jul 2026US 2026/0218241 A1Massachusetts Institute of Technology
- Orthogonal Cas9 Proteins for RNA-Guided Gene Regulation and Editing11 Jun 2026US 2026/0159856 A1President and Fellows of Harvard College
- Chemically-modified adeno-associated viruses30 Oct 2025US 2025/0332286 A1Centre National De La Recherche Scientifique
- Engineered multi-component system for identification and characterisation of t-cell receptors and t-cell antigens25 Sep 2025US 2025/0297211 A1Genovie AB
Most cited
By later US patents
- Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation489US 8,865,406 B2Massachusetts Institute of Technology · 2014
- Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation451US 8,889,418 B2Massachusetts Institute of Technology · 2014
- Engineering and optimization of improved systems, methods and enzyme compositions for sequence manipulation422US 8,895,308 B1Massachusetts Institute of Technology · 2014
- CNS targeting AAV vectors and methods of use thereof91US 9,102,949 B2University of Massachusetts · 2015
- Orthogonal Cas9 proteins for RNA-guided gene regulation and editing86US 9,587,252 B2President and Fellows of Harvard College · 2017